Ua loaʻa iā Optellum ka mākaʻikaʻi CE no kāna Virtual Nodule Clinic, kahi lako polokalamu kākoʻo hoʻoholo hoʻoholo hoʻoholo AI-powered e kōkua i nā kauka e ʻike a nānā i nā poʻe maʻi pilikia e hōʻike ana i nā nodules māmā kānalua a i ʻole ka maʻi kanesa.
Hiki i kēia palapala hōʻoia hou ke hoʻohana i ka European Union (EU) a me United Kingdom (UK), a wehe i ka puka i kahi hoʻonui ʻEulopa no ka ʻoihana ulu. ʻO ia ka milestone hou loa no Optellum, i loaʻa iā FDA 510 (k) hoʻomaʻemaʻe i ka hoʻomaka ʻana o 2021 ma ke ʻano he noi mua i kōkua ʻia e AI no ka maʻi kanesa. Mai ia manawa, ua kākoʻo ʻia ka hui e ka hui pū ʻana me ka National Health Service (NHS) me ke kālā mai Innovate UK a me ka National Institute for Health Research (NIHR), a ua hoʻokō ʻia no ka hoʻohana maʻi i kekahi mau haukapila US alakaʻi honua e like me ʻO Atrium Wake Forest Baptist, Vanderbilt University Medical Center (VUMC) a me ke Kulanui o Mississippi Medical Center (UMMC).
Hoʻohui ka Virtual Nodule Clinic i ka helu ʻo Lung Cancer Prediction (LCP) i hoʻopaʻa ʻia ma ke kiʻi kiʻi AI a loaʻa iā ia ka hiki ke hoʻomaikaʻi i ka hoʻonohonoho ʻana i ka mālama lapaʻau a me nā hoʻoholo, me ka manaʻo e mālama ʻia nā mea maʻi ma mua o ka hiki ʻana o ka maʻi maʻi, a laila e hoʻonui nui i ke ola maʻi maʻi maʻi. uku.
'O ka ma'i 'a'ai 'o ka ma'i 'a'ai 'oi loa ka nui o ka make ma mua o nā ma'i 'a'ai a pau, me ka helu ola 'elima makahiki i kēia manawa he 20 pakeneka. Eia nō naʻe, ʻo ka nui o ke ola ʻana no nā maʻi ʻaʻa liʻiliʻi i mālama ʻia ma Stage IA a hiki i 90% - kahi ʻokoʻa e hōʻike ana i ka pono koʻikoʻi no ka maʻi maʻi a me ka mālama ʻana i ka pae mua loa.1
Ke hoʻokele ʻia nei ka paepae ma nā halemai NHS he ʻumi ma ke ʻano he DOLCE, kahi papahana noiʻi ʻāina i alakaʻi ʻia e Professor David Baldwin, ʻo ia ka Luna Hoʻohanohano o ka lāʻau lapaʻau ma ke Kulanui o Nottingham, a me ke Kauka Kūkākūkā ma Nottingham University Hospitals NHS Trust. ʻO ka papahana kahi ʻāpana o ka NHS AI Lab's £ 140 miliona AI i ka Health and Care Award e hoʻolalelale i ka hoʻāʻo ʻana a me ka loiloi ʻana o AI i ka NHS i hiki i nā poʻe maʻi ke pōmaikaʻi mai ka maʻi wikiwiki a ʻoi aku ka pilikino a me ka ʻoi aku ka maikaʻi o nā lawelawe screening.
Ua ʻōlelo ʻo Polofesa Baldwin: "He mau hōʻike ikaika mai ka noiʻi ʻana i hana ʻia e kēia AI-based Lung Cancer Prediction mea hana ʻoi aku ka maikaʻi o ka hoʻokaʻawale ʻana i ka benign mai nā nodules malignant me ka hiki ke mālama i ke kālā NHS i hoʻohana ʻia i kēia manawa no ka hoʻihoʻi ʻana i ka CT scans. Ke manaʻo nei ka noiʻi DOLCE e hōʻoia i nā hopena a me ka helu ʻana i kēlā mālama ʻana, a ʻo ia ka hana hope loa i ka hoʻokō piha ʻana i ka NHS.
ʻO Optellum nō hoʻi ke alakaʻi ʻoihana hoa hana ma ka UK's DART (Data Using Artificial Intelligence to Improve Patient Outcomes with Thoracic Diseases) consortium, e hana pū ana me ka NHS England's Targeted Lung Health Check program, e hāʻawi i ka nānā ʻana i ka maʻi kanesa ma kahi o 600,000 mau kānaka kūpono.
Ua ʻōlelo ʻo Jason Pesterfield, Luna Hoʻokele o Optellum: "ʻO ka loaʻa ʻana o ka mākaʻikaʻi CE e ʻae iā mākou e hoʻohana i kā mākou AI hou i nā kahua lapaʻau UK e kū nei, e hiki ai i nā kauka a me nā mea maʻi ke pōmaikaʻi mai kā mākou ʻenehana me ka ʻole o ka lohi. E ʻae ia iā mākou e hoʻonui i kā mākou kūʻai kūʻai aku i ʻEulopa a hoʻonui i kā mākou hui pū ʻana me kekahi o nā haukapila a me nā keʻena i lilo i ʻāpana o kā mākou hoʻomohala huahana mua.
Ua hōʻike hou ʻia ʻo Optellum i ka Health Education England's AI Roadmap Report2, nāna i loiloi i ka mākaukau o ka NHS no ka hoʻokō ʻana i nā ʻenehana AI hou a me ka hopena o kēia mau ʻenehana i ka limahana, ke ala hoʻomanawanui, a me ka hana ʻōnaehana ākea.
He aha e lawe ʻia mai kēia ʻatikala:
- The project is part of the NHS AI Lab’s £140 million AI in Health and Care Award to accelerate the testing and evaluation of AI in the NHS so patients can benefit from faster and more personalised diagnosis and greater efficiency in screening services.
- Since then, the company has been supported by partnerships with the National Health Service (NHS) with funding from Innovate UK and the National Institute for Health Research (NIHR), and has been implemented for patient use in several world-leading US hospitals such as Atrium Wake Forest Baptist, Vanderbilt University Medical Center (VUMC) and the University of Mississippi Medical Center (UMMC).
- The platform is currently being piloted at ten NHS hospitals as part of DOLCE, a landmark research project led by Professor David Baldwin, who is Honorary Professor of Medicine at the University of Nottingham, and Consultant Physician at Nottingham University Hospitals NHS Trust.
